Edit |   |
---|---|
Antigenic Specificity | CD37, Human (Otlertuzumab biosimilar) |
Clone | Otlertuzumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | VH-V kappa-CH2-CH3 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IP, FCM, FuncS, Neut, IF, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD37 Recombinant Antibody (Otlertuzumab). Otlertuzumab (TRU- 016) is a humanized monoclonal antibody that targets CD37 designed for the treatment of cancer. This drug was developed by Emergent BioSolutions and has been in clinical trails for lymphoma and Chronic Lymphocytic Leukemia (CLL). |
Immunogen | n/a |
Other Names | Anti-CD37 Recombinant Antibody, Research Grade Otlertuzumab, Anti-Human CD37 Recombinant Antibody(Otlertuzumab), TRU-016, Antibody Drug Analogues, Monoclonal Antibody, YR1329, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1372645-37-8 |
Catalog # | YR1329 |
Price | please inquire |
Order / More Info | CD37, Human (Otlertuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |